Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?

Source: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-28-to-october-4-2026
Scope: Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop
Family: Ranking Top 10
Observed: Sep 28 – Oct 4, 2026 (2026-09-28/2026-10-04)
Published: October 6, 2026
Method — How readings are scoped: https://theobservatory.io/method#standards
Method — Run metadata: https://theobservatory.io/method/panel#run-metadata
Method — Source protocol: https://theobservatory.io/method#source-protocol
Method — Corrections and right of reply: https://theobservatory.io/method#corrections
Public table: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-28-to-october-4-2026/data.csv
Citation text: https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-28-to-october-4-2026/citation.txt
Reuse terms: https://theobservatory.io/terms

reddit.com holds the strongest AI opening share on the Luxury Medical Aesthetic Clinics Seoul market across the 6-run observation period (September 28 – October 4, 2026), at 13.71%.

Key facts:
• reddit.com: 14% AI opening share · opening in 6/6 runs
• instagram.com: 13% AI opening share · opening in 6/6 runs
• us-uk.bookimed.com: 13% AI opening share · opening in 6/6 runs

Published table — AIO opening control — top 10 (Sep 28 – Oct 4, 2026 · 80 queries per run · 6 comparable runs): Rank · Actor · AIO opening control
1. reddit.com — 13.71% AI opening share · opening in 6/6 runs — #1
2. instagram.com — 12.90% AI opening share · opening in 6/6 runs — #2
3. us-uk.bookimed.com — 12.90% AI opening share · opening in 6/6 runs — #3
4. youtube.com — 8.06% AI opening share · opening in 6/6 runs — #4
5. seoulcosmeticsurgery.com — 6.05% AI opening share · opening in 6/6 runs — #5
6. facebook.com — 4.84% AI opening share · opening in 5/6 runs — #6
7. linkpskorea.com — 4.44% AI opening share · opening in 3/6 runs — #7
8. enlienjang.com — 4.03% AI opening share · opening in 5/6 runs — #8
9. placidway.com — 4.03% AI opening share · opening in 3/6 runs — #9
10. jivaka.kr — 3.63% AI opening share · opening in 4/6 runs — #10

Reading basis: This card observes the AI Overview opening-control rail for Luxury Medical Aesthetic Clinics Seoul in South Korea on Google desktop across 6 comparable scheduled runs in the observation period September 28 – October 4, 2026. The governed top-10 panel is aggregated from 80 observed queries. Per-actor AI opening share is the sum of the actor's opening values across all comparable runs in the period, divided by one single period-wide denominator. The primary metric is AI opening share on this market. AI Overview opening-control evidence was available on 6 of 6 runs in the comparable window.

Limitations and non-claims:
— Observes the observed AI answer surface only; within a defined scope and window.
— A period aggregate (6 comparable runs) — not a claim about bookings, revenue, or market share.
— Scoped to Luxury Medical Aesthetic Clinics Seoul Seoul, October 2026; not generalisable beyond this market and window.

— The Observatory · Luxury Medical Aesthetic Clinics Seoul · Seoul · AI Overview · Google · Desktop · Sep 28 – Oct 4, 2026
Based on governed AAI Kernel evidence. Capture identifier: pr_1791071417052_b3zpq9. Cite freely with attribution. Published by The Observatory.
Source footnote: Sourced from a published AAI MIB card. The Observatory publishes this card’s public findings; values are as observed on the search surface, not business-market claims.
Attribution: Published by The Observatory · Based on an AAI Kernel capture · governed by The Observatory editorial system
Cite: According to The Observatory (October 6, 2026), Who controls Google's AI Overview for Luxury Medical Aesthetic Clinics Seoul?. https://theobservatory.io/articles/aesthetic-clinics-seoul-ai-overview-control-september-28-to-october-4-2026

This record is the published reading and its public table/slice as served on the card — not the complete underlying capture or provider dataset.
Observed by The Observatory. Not an endorsement, recommendation, market-share claim or commercial ranking.
Free reuse, including commercial republication, under The Observatory’s Terms. Retain attribution, source link, scope and date.
Revision: 8ed3ef654d0e5df7